Skip to main content

Table 1 Demographic, clinical and microbiological data of 92 subjects

From: Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis

  Septicemic melioidosis Other sepsis Recovery Type 2 diabetes Healthy
Training set (n = 34)      
   Number of subjects 11 13 5 5  
   Mean age in years (range) 54 (41-70) 56 (37-74) 46 (41-64) 40 (39-68)  
   Sex (male/female) 7/4 4/9 3/2 1/4  
   Survivors/non-survivors 6/5 11/2    
   Organisms (n) B. pseudomallei (11) A. baumannii (1)    
   Corynebacterium spp. (2)    
   C. albicans (3)    
   E. coli (3)    
   Salmonella serotype B (1)    
   S. aureus (1)    
   Salmonella spp. (1)    
   Non-group A or B Streptococcus (1)    
Independent test set 1 (n = 33)      
   Number of subjects 13 11 4 2 3
   Mean age in years (range) 50 (18-70) 56 (37-70) 50 (39-64) 49 (48-50) 38 (35-43)
   Sex (male/female) 11/2 6/5 3/1 0/2 0/3
   Survivors/non-survivors 12/1 6/5    
   Organisms (n) B. pseudomallei (13) Coagulase-negative staphylococci (6)*    
   E. coli (1)    
   Enterococcus spp. (1)    
   S. aureus (1)    
   K. pneumoniae (1)    
   S. pneumoniae (1)    
Independent test set 2 (n = 25)      
   Number of subjects 8 7   5 5
   Mean age in years (range) 47 (40-56) 61 (43-81)   57 (50-71) 44 (37-67)
   Sex (male/female) 4/4 2/5   0/5 3/2
   Survivors/non-survivors 3/5 5/2   5/0 5/0
   Organisms (n) B. pseudomallei (8) A. hydrophila (1)    
   Corynebacterium spp. (1)    
   E. coli (2)    
   S. aureus (1)    
   Enterococcus spp. (1)    
   E. faecium (1)    
  1. *Three in six patients were positive in two sets of blood cultures. Patients were positive in two sets of blood cultures.